The rising interest in GLP-1 agonists for diabetes has generated a discussion about application forms : patches versus tablets . Traditionally , GLP-1 therapies were exclusively available in tablet form, https://lewisncxk308453.newbigblog.com/47855854/glp-1-transdermal-delivery-systems-vs-tablets-is-suitable-for-the-patient